J.ophthalmol.(Ukraine).2018;3:32-40.

https://doi.org/10.31288/oftalmolzh201833240


Distribution of polymorphic genotypes of GSTP1, GSTM1 and GSTT1 and their association with primary open-angle glaucoma

S.O. Rykov1, Dr Sc (Med), Prof., A.V. Burdei, Postgraduate, Ophthalmologist, S.V. Ziablitsev2, Dr Sc (Med), Prof., S.Iu. Mogilevskyy1, Dr Sc (Med), Prof.

1 Shupik National Medical Academy of Postgraduate Education; Kyiv (Ukraine)

2 Bohomolets National Medical University; Kyiv (Ukraine)

E-mail: eye-bolit@ukr.net                       

TO CITE THIS ARTICLE: Rykov SO, Burdei AV, Ziablitsev SV, Mogilevskyy SIu. Distribution of polymorphic genotypes of GSTP1, GSTM1 and GSTT1 and their association with primary open-angle glaucoma.  J.ophthalmol.(Ukraine).2018;3:32-40. https://doi.org/10.31288/oftalmolzh201833240

  

Background: The role of genetic factors in the development of primary open-angle glaucoma (POAG) has been confirmed previously. Activation of oxidative stress with a reduction in the activity of glutathione S transferase (GST) family enzymes is a major mechanism in the pathogenesis of POAG. Since there are substantial population differences in frequencies of GST polymorphisms and there are contradictory reports regarding the association between GST polymorphisms and POAG, we considered it reasonable to investigate these polymorphisms in a Ukrainian population of patients with POAG.

Purpose: To investigate the distribution of polymorphic genotypes of GSTP1, GSTM1 and GSTT1 and their associations with the development and progression of POAG.

Materials and Methods: One hundred and seventy two patients (344 eyes) diagnosed with POAG were involved into the study. In addition, the control group comprised 98 volunteers (196 eyes) diagnosed with no POAG. Patients were divided into four groups based on the stages of glaucoma identified by Nesterov (2008): Group 1 (mild POAG; 38 patients), Group 2 (moderately advanced POAG; 44 patients), Group 3 (far advanced disease with markedly constricted visual fields; 40 patients), and Group 4 (terminal stage POAG, with developed blindness; 50 patients). The polymorphisms were determined using real-time polymerase chain reaction and TaqMan Mutation Detection Assays (Life Technologies). Statistical analyses were performed using MedStat and MedCalc v.15.1 (MedCalc Software bvba).

Results and Discussion: We identified 11 combinations of genetic variants which were significantly different in frequency between patients with POAG and controls and between different groups of patients (χ2=112.63; p=0.00Е-01). In addition, we revealed significant differences in the distribution of genotypes between total patients with POAG and controls (χ2=54.68, p=0.00Е-01). The frequencies of the polymorphisms in the controls were different from those observed in glaucoma patients in Group 1 and Group 2 (p(χ2)=0.001 and p(χ2)=0.003, respectively), and Groups 3 and 4 (p(χ2)= 0.00Е-01). The risk for the development of stage 1 POAG was 15-fold increased in patients exhibiting the combination of GSTP1(Val/Val), GSTM1-null and GSTT1+ genotypes. The combination of GSTP1(Ile/Ile), GSTM1-null and GSTT1-null genotypes was associated with the progression of the disease, with 5.1-fold, 6.6-fold, and 13-fold increased risks for development of stage 2, stage 3 or stage 4 POAG, respectively. The combinations including the ancestral genotype GSTP1(Ile/Ile) with GSTM1 and/or GSTT1 non-null genotypes were found to be protective against progression of POAG.

Conclusion: The polymorphic genotypes of GSTP1, GSTM1 and GSTT1 which result in reduced antioxidative activity are essential in both the incidence and progression of POAG. The combinations including the GSTM1 and GSTT1 mutant (null) alleles were found to be pathological, whereas those including the ancestral genotype GSTP1(Ile/Ile) with GSTM1+ and/or GSTT1 +  were found to be protective against progression of POAG.

Keywords: primary open-angle glaucoma, glutathione S transferase genes, GSTP1, GSTM1, GSTT1

References

1.Yu Y, Weng Y, Guo J, Chen G, Yao K. Association of glutathione S transferases polymphisms with glaucoma: a meta-analysis. PLoS ONE. 2013;8(1): e54037.
Crossref   Pubmed

2.Quigley HA, Broman AT. [The number of people with glaucoma worldwide in 2010 and 2020]. Br J Ophthalmol. 2006 Mar;90(3):262-7.
Crossref   Pubmed

3.Kirilenko MYu, Churnosov MI. [Genetic research of primary open-angle glaucoma]. Bulletin of Tambov University. Series: Natural and Technical Sciences. 2014;19(4):1140-2. Russian.

4.Fingert JH. Primary open-angle glaucoma genes. Eye (Lond). 2011;25(5);587-95. 
Crossref   Pubmed

5.Mogilevskyy SIu, Ziablitsev SV, Denisiuk LI. [Gender and age-related features of the association between TP53 Pro72Arg polymorphism and primary open-angle glaucoma]. Journal of Ophthalmology (Ukraine). 2016;4:15-19. Ukrainian

6.Mogilevskyy SIu, Ziablitsev SV, Denisiuk LI, Gur’ianov VG. [Mathematical analysis of the effect of Pro72Arg polymorphism in the TP53 gene on the emergence and progression of POAG]. Journal of Ophthalmology (Ukraine). 2016;6:32-7. Ukrainian

7.Kolesov SA, Rakhmanov RS, Blinova ТV, Strakhova LA. [New data on the diagnostic potential of cytosolic glutathione S-transferases]. Int  J Applied and Basic Research. 2016;3:577-80. Russian.

8.Teplyakov AT, Berezikova EN, Shilov SN. [Heart failure: Clinical and genetic aspects of ischemic remodeling and myocardial apoptosis in the development of heart failure]. Tomsk: SST. 2015. Russian.

9.Wang W, Zhou M,, Chen S, Zhang X. Association of glutathione S-transferase polymorphisms (GSTM1 and GSTT1) with primary open-angle glaucoma: an evidence-based meta-analysis. Gene. 2013;526(2):80-6.
Crossref   Pubmed

10.Rykov SA, Burdei AV. [Association of deletion polymorphisms of the glutathione-S-transferase gene in patients with primary open-angle glaucoma]. Archive of Ophthalmology of Ukraine. 2017;5;3(9):61-7. Ukrainian.

11.Izzotti А, SaccaS.С., Longobardi M, Cartiglia C. Sensitivity of ocular anterior chamber tissues to oxidative damage and its relevance to the pathogenesis of glaucoma. Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5251-8.

12.Nesterov AP. [Glaucoma]. Moscow: Meditsinskoye Informatsionnoye Agenstvo; 2008 Russian.

13.Erichev VP, Egorov EA. [On the pathogenesis of primary open-angle glaucoma]. Vestn Oftalmol. 2014 Nov-Dec;130(6):98-104. Russian.